Related Experiment Video
Updated: Aug 30, 2026

Development of a Cabbage Protoplast System for Studying Hypoxia Tolerance in Brassica
Published on: September 20, 2024
Transcriptional regulation of cyclo-oxygenase expression: three pillars of control
R G Ramsay1, D Ciznadija, M Vanevski
1Differentiation and Transcription Group, Trescowthick Laboratories, Peter MacCallum Cancer Centre, Locked Bag #1 A' Beckett Street, Victoria, 8006, Australia. Rob.Ramsay@Petermac.org
Abstract:
Blocking cyclo-oxygenase (COX) isoform activities with non-steroidal anti-inflammatory drugs (NSAIDS) is widely employed in the treatment of arthritis. These agents also hold great promise in the context of pre and post-neoplastic diseases such as colorectal cancer (CRC). Nevertheless, issues of isoform specificity and delivery necessitate the exploration of other strategies to specifically block expression of the COX genes. Approaches that target gene transcription may complement enzyme inhibition. Thus, understanding the regulation of COX isoform transcription may improve the specific inhibition of expression. Three tiers of transcriptional regulation are evident: initiation, alternative splicing and messenger RNA stability. Transcription factors that activate COX-2 expression are elevated in certain disease states and emergency responses such as infection and are therefore potential targets. These factors include C/EBP-beta, phospho- CREB, NF-IL6, AP1, NFkB, and TCF-4/LEF-1. In this review we highlight another factor, c-MYB as a key COX-2 regulator in CRC. Alternative exon usage is another tier of regulation that has not received much attention. For instance, COX-1 splice variants (also known as COX-3 and PCOX-1a) may broaden the spectrum of COX activities in disease. Similarly, whilst mRNA stability is clearly modulated by steroids in the case of COX-2, the wider implications of targeting mRNA stability have not been afforded the same attention. Finally, it seems that some NSAIDS exert part of their action directly on COX-2 transcriptional regulation explaining why such agents display greater effects on this isoform than enzyme inhibition data would suggest.
Insights
Non-steroidal anti-inflammatory drugs (NSAIDs) target cyclo-oxygenase (COX) enzymes. New strategies focus on regulating COX gene transcription, including c-MYB, for better specificity in treating diseases like colorectal cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) are used to treat arthritis by blocking cyclo-oxygenase (COX) isoform activity.
- NSAIDs show promise in managing pre- and post-neoplastic diseases, including colorectal cancer (CRC).
- Current strategies face challenges with isoform specificity and drug delivery, necessitating alternative approaches.
Purpose of the Study:
- To explore strategies for specifically blocking COX gene expression by targeting transcriptional regulation.
- To understand the regulation of COX isoform transcription for improved, specific inhibition.
- To highlight c-MYB as a key regulator of COX-2 in colorectal cancer.
Main Methods:
- Review of existing literature on COX isoform regulation at the transcriptional level.
- Analysis of transcriptional regulation tiers: initiation, alternative splicing, and mRNA stability.
- Identification of key transcription factors involved in COX-2 expression, including c-MYB.
Main Results:
- COX-2 expression is regulated by multiple tiers, including transcription factor activation, alternative splicing, and mRNA stability.
- Transcription factors such as C/EBP-beta, phospho-CREB, NF-IL6, AP1, NFkB, TCF-4/LEF-1, and c-MYB are implicated in COX-2 regulation.
- COX-1 splice variants (COX-3, PCOX-1a) and mRNA stability modulation represent under-explored regulatory mechanisms.
Conclusions:
- Targeting COX gene transcription offers a promising complementary strategy to enzyme inhibition for specific COX isoform blockade.
- Understanding transcriptional regulation, including the role of c-MYB in CRC, can enhance therapeutic specificity.
- Further research into alternative splicing and mRNA stability of COX isoforms may reveal new therapeutic targets.
Related Concept Videos
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Master Transcription Regulators
Master Transcription Regulators
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Regulation of Expression at Multiple Steps

